Disease-Free Survival With Longer Follow-Up From The Phase 3 Checkmate 274 Trial Of Adjuvant Nivolumab In Patients Who Underwent Surgery For High-Risk Muscle-Invasive Urothelial Carcinoma
Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Disease-Free Survival With Longer Follow-Up From The Phase 3 Checkmate 274 Trial Of Adjuvant Nivolumab In Patients Who Underwent Surgery For High-Risk Muscle-Invasive Urothelial Carcinoma ### Output: Nivolumab